An experimental new treatment is showing early promise in the fight against liver fibrosis – a serious and often silent ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...

Liver disease is a modifiable cardiac risk factor, and this study confirmed that it can be quantified with MRI iron corrected ...

It's a key component of weight lost and diabetes drugs and researchers have found it can do wonders for those who have ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of ...

To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...

An experimental new treatment is showing early promise in the fight against liver fibrosis - a serious and often silent condition that affects around ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial ...

The meeting in Grand Rivers will include talk of research plans set for Livingston, Marshall, McCracken, and other Western ...

Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...

Obicetrapib provided dramatic reductions in LDL cholesterol, without noticeable side effects, in a phase III trial of ...